Pre Seed · Biotech · Cambridge, United Kingdom · Founded 2024 · 1–10 employees
Tolemy Bio is a biotech company developing Orbit, an AI-native virtual cell software platform designed to accelerate therapeutic development and biomanufacturing. By ingesting disconnected laboratory and manufacturing data, the platform employs causal AI models to run virtual simulations that predict cellular behaviors. In May 2026, the company secured a 1.4 million EUR funding round to advance its technology and expand operations. The startup is incubated by deep tech accelerator Science Creates and maintains offices in both the United Kingdom and Spain.
No open roles listed right now.